世界のフルタミド市場レポート2020年

QYResearchが発行した調査報告書(QYR20ST06955)
◆英語タイトル:Global Flutamide (CAS 13311-84-7) Sales Market Report 2020
◆商品コード:QYR20ST06955
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年9月(※2024年版があります。お問い合わせください。)
◆ページ数:131
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、北米、ヨーロッパ、日本、アジアなど
◆産業分野:医薬品、医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥888,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

QYリサーチ社の本調査レポートでは、世界のフルタミド市場について種類別(フルタミド錠、フルタミドカプセル、その他)、用途別(病院薬局、小売薬局、オンライン薬局)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・フルタミド市場の概要
・世界の主要地域別フルタミド市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のフルタミド市場規模2015-2026:種類別(フルタミド錠、フルタミドカプセル、その他)
・世界のフルタミド市場規模2015-2026:用途別(病院薬局、小売薬局、オンライン薬局)
・フルタミドの北米市場規模2015-2020
・フルタミドのヨーロッパ市場規模2015-2020
・フルタミドの中国市場規模2015-2020
・フルタミドの日本市場規模2015-2020
・フルタミドの東南アジア市場規模2015-2020
・フルタミドのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・フルタミドの製造コスト分析
・販売チャネル、流通業者、顧客
・フルタミドの市場動向・機会・課題
・調査の結論
【レポートの概要】

A recently published report by QY Research titled Global Flutamide (CAS 13311-84-7) Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Flutamide (CAS 13311-84-7) market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Flutamide (CAS 13311-84-7), C11H11F3N2O3, the formula weight is 276.21, and its form is yellow powder.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Flutamide (CAS 13311-84-7) market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Flutamide (CAS 13311-84-7) industry.
Based on our recent survey, we have several different scenarios about the Flutamide (CAS 13311-84-7) YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Flutamide (CAS 13311-84-7) will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Flutamide (CAS 13311-84-7) market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Flutamide (CAS 13311-84-7) market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Flutamide (CAS 13311-84-7) market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Flutamide (CAS 13311-84-7) market. The report also includes nautical information, where it shows Flutamide (CAS 13311-84-7) market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Flutamide (CAS 13311-84-7) market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Flutamide (CAS 13311-84-7) market.
Flutamide is used for prostate cancer or benign prostatic hypertrophy. This product can be combined with leucolide to treat metastatic prostate cancer, which can significantly increase the efficacy.
Geographical Analysis:
Based on region, the global Flutamide (CAS 13311-84-7) market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Flutamide (CAS 13311-84-7) market are
Forward
Merck
Tasly Diyi Pharma
Cipla LifeScience
Actiza Pharma
TEVA Pharma
Florencia Healthcare
SANDOZ
Segment by Type
Flutamide Tablets
Flutamide Capsule
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Flutamide (CAS 13311-84-7) market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Flutamide (CAS 13311-84-7) market.
• The market share of the global Flutamide (CAS 13311-84-7) market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Flutamide (CAS 13311-84-7) market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Flutamide (CAS 13311-84-7) market.

【レポートの目次】

1 Flutamide (CAS 13311-84-7) Market Overview
1.1 Flutamide (CAS 13311-84-7) Product Scope
1.2 Flutamide (CAS 13311-84-7) Segment by Type
1.2.1 Global Flutamide (CAS 13311-84-7) Sales by Type (2020-2026)
1.2.2 Flutamide Tablets
1.2.3 Flutamide Capsule
1.2.4 Others
1.3 Flutamide (CAS 13311-84-7) Segment by Application
1.3.1 Global Flutamide (CAS 13311-84-7) Sales Comparison by Application (2020-2026)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Flutamide (CAS 13311-84-7) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Flutamide (CAS 13311-84-7) Sales Growth Rate (2015-2026)
1.4.2 Global Flutamide (CAS 13311-84-7) Revenue and Growth Rate (2015-2026)
1.4.3 Global Flutamide (CAS 13311-84-7) Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Flutamide (CAS 13311-84-7) Industry Impact
1.5.1 How the Covid-19 is Affecting the Flutamide (CAS 13311-84-7) Industry
1.5.1.1 Flutamide (CAS 13311-84-7) Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Flutamide (CAS 13311-84-7) Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Flutamide (CAS 13311-84-7) Players to Combat Covid-19 Impact

2 Flutamide (CAS 13311-84-7) Estimate and Forecast by Region
2.1 Global Flutamide (CAS 13311-84-7) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Flutamide (CAS 13311-84-7) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Flutamide (CAS 13311-84-7) Sales Market Share by Region (2015-2020)
2.2.2 Global Flutamide (CAS 13311-84-7) Revenue Market Share by Region (2015-2020)
2.3 Global Flutamide (CAS 13311-84-7) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Flutamide (CAS 13311-84-7) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Flutamide (CAS 13311-84-7) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Flutamide (CAS 13311-84-7) Estimates and Projections (2015-2026)
2.4.2 Europe Flutamide (CAS 13311-84-7) Estimates and Projections (2015-2026)
2.4.3 China Flutamide (CAS 13311-84-7) Estimates and Projections (2015-2026)
2.4.4 Japan Flutamide (CAS 13311-84-7) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Flutamide (CAS 13311-84-7) Estimates and Projections (2015-2026)
2.4.6 India Flutamide (CAS 13311-84-7) Estimates and Projections (2015-2026)
3 Global Flutamide (CAS 13311-84-7) Competition Landscape by Players
3.1 Global Top Flutamide (CAS 13311-84-7) Players by Sales (2015-2020)
3.2 Global Top Flutamide (CAS 13311-84-7) Players by Revenue (2015-2020)
3.3 Global Flutamide (CAS 13311-84-7) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Flutamide (CAS 13311-84-7) as of 2019)
3.4 Global Flutamide (CAS 13311-84-7) Average Price by Company (2015-2020)
3.5 Manufacturers Flutamide (CAS 13311-84-7) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Flutamide (CAS 13311-84-7) Players (Opinion Leaders)
4 Global Flutamide (CAS 13311-84-7) Market Size by Type
4.1 Global Flutamide (CAS 13311-84-7) Historic Market Review by Type (2015-2020)
4.1.1 Global Flutamide (CAS 13311-84-7) Sales Market Share by Type (2015-2020)
4.1.2 Global Flutamide (CAS 13311-84-7) Revenue Market Share by Type (2015-2020)
4.1.3 Global Flutamide (CAS 13311-84-7) Price by Type (2014-2020)
4.2 Global Flutamide (CAS 13311-84-7) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Flutamide (CAS 13311-84-7) Sales Forecast by Type (2021-2026)
4.2.2 Global Flutamide (CAS 13311-84-7) Revenue Forecast by Type (2021-2026)
4.2.3 Global Flutamide (CAS 13311-84-7) Price Forecast by Type (2021-2026)
5 Global Flutamide (CAS 13311-84-7) Market Size by Application
5.1 Global Flutamide (CAS 13311-84-7) Historic Market Review by Application (2015-2020)
5.1.1 Global Flutamide (CAS 13311-84-7) Sales Market Share by Application (2015-2020)
5.1.2 Global Flutamide (CAS 13311-84-7) Revenue Market Share by Application (2015-2020)
5.1.3 Global Flutamide (CAS 13311-84-7) Price by Application (2015-2020)
5.2 Global Flutamide (CAS 13311-84-7) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Flutamide (CAS 13311-84-7) Sales Forecast by Application (2021-2026)
5.2.2 Global Flutamide (CAS 13311-84-7) Revenue Forecast by Application (2021-2026)
5.2.3 Global Flutamide (CAS 13311-84-7) Price Forecast by Application (2021-2026)

3 North America Flutamide (CAS 13311-84-7) Market Facts & Figures
3.2 North America Flutamide (CAS 13311-84-7) Sales Market Share by Company (2015-2020)
3.3 North America Flutamide (CAS 13311-84-7) Sales Market Share by Type (2015-2020)
3.4 North America Flutamide (CAS 13311-84-7) Sales Market Share by Application (2015-2020)

4 Europe Flutamide (CAS 13311-84-7) Market Facts & Figures
4.2 Europe Flutamide (CAS 13311-84-7) Sales Market Share by Company (2015-2020)
4.3 Europe Flutamide (CAS 13311-84-7) Sales Market Share by Type (2015-2020)
4.4 Europe Flutamide (CAS 13311-84-7) Sales Market Share by Application (2015-2020)

5 China Flutamide (CAS 13311-84-7) Market Facts & Figures
5.2 China Flutamide (CAS 13311-84-7) Sales Market Share by Company (2015-2020)
5.3 China Flutamide (CAS 13311-84-7) Sales Market Share by Type (2015-2020)
5.4 China Flutamide (CAS 13311-84-7) Sales Market Share by Application (2015-2020)

6 Japan Flutamide (CAS 13311-84-7) Market Facts & Figures
6.2 Japan Flutamide (CAS 13311-84-7) Sales Market Share by Company (2015-2020)
6.3 Japan Flutamide (CAS 13311-84-7) Sales Market Share by Type (2015-2020)
6.4 Japan Flutamide (CAS 13311-84-7) Sales Market Share by Application (2015-2020)

7 Southeast Asia Flutamide (CAS 13311-84-7) Market Facts & Figures
7.2 Southeast Asia Flutamide (CAS 13311-84-7) Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Flutamide (CAS 13311-84-7) Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Flutamide (CAS 13311-84-7) Sales Market Share by Application (2015-2020)

8 India Flutamide (CAS 13311-84-7) Market Facts & Figures
8.2 India Flutamide (CAS 13311-84-7) Sales Market Share by Company (2015-2020)
8.3 India Flutamide (CAS 13311-84-7) Sales Market Share by Type (2015-2020)
8.4 India Flutamide (CAS 13311-84-7) Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Flutamide (CAS 13311-84-7) Business
12.1 Forward
12.1.1 Forward Flutamide (CAS 13311-84-7) Corporation Information
12.1.2 Forward Flutamide (CAS 13311-84-7) Business Overview and Total Revenue
12.1.3 Forward Flutamide (CAS 13311-84-7) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Forward Flutamide (CAS 13311-84-7) Products Offered
12.1.5 Forward Recent Development
12.2 Merck
12.2.1 Merck Flutamide (CAS 13311-84-7) Corporation Information
12.2.2 Merck Flutamide (CAS 13311-84-7) Business Overview and Total Revenue
12.2.3 Merck Flutamide (CAS 13311-84-7) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merck Flutamide (CAS 13311-84-7) Products Offered
12.2.5 Merck Recent Development
12.3 Tasly Diyi Pharma
12.3.1 Tasly Diyi Pharma Flutamide (CAS 13311-84-7) Corporation Information
12.3.2 Tasly Diyi Pharma Flutamide (CAS 13311-84-7) Business Overview and Total Revenue
12.3.3 Tasly Diyi Pharma Flutamide (CAS 13311-84-7) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Tasly Diyi Pharma Flutamide (CAS 13311-84-7) Products Offered
12.3.5 Tasly Diyi Pharma Recent Development
12.4 Cipla LifeScience
12.4.1 Cipla LifeScience Flutamide (CAS 13311-84-7) Corporation Information
12.4.2 Cipla LifeScience Flutamide (CAS 13311-84-7) Business Overview and Total Revenue
12.4.3 Cipla LifeScience Flutamide (CAS 13311-84-7) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Cipla LifeScience Flutamide (CAS 13311-84-7) Products Offered
12.4.5 Cipla LifeScience Recent Development
12.5 Actiza Pharma
12.5.1 Actiza Pharma Flutamide (CAS 13311-84-7) Corporation Information
12.5.2 Actiza Pharma Flutamide (CAS 13311-84-7) Business Overview and Total Revenue
12.5.3 Actiza Pharma Flutamide (CAS 13311-84-7) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Actiza Pharma Flutamide (CAS 13311-84-7) Products Offered
12.5.5 Actiza Pharma Recent Development
12.6 TEVA Pharma
12.6.1 TEVA Pharma Flutamide (CAS 13311-84-7) Corporation Information
12.6.2 TEVA Pharma Flutamide (CAS 13311-84-7) Business Overview and Total Revenue
12.6.3 TEVA Pharma Flutamide (CAS 13311-84-7) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 TEVA Pharma Flutamide (CAS 13311-84-7) Products Offered
12.6.5 TEVA Pharma Recent Development
12.7 Florencia Healthcare
12.7.1 Florencia Healthcare Flutamide (CAS 13311-84-7) Corporation Information
12.7.2 Florencia Healthcare Flutamide (CAS 13311-84-7) Business Overview and Total Revenue
12.7.3 Florencia Healthcare Flutamide (CAS 13311-84-7) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Florencia Healthcare Flutamide (CAS 13311-84-7) Products Offered
12.7.5 Florencia Healthcare Recent Development
12.8 SANDOZ
12.8.1 SANDOZ Flutamide (CAS 13311-84-7) Corporation Information
12.8.2 SANDOZ Flutamide (CAS 13311-84-7) Business Overview and Total Revenue
12.8.3 SANDOZ Flutamide (CAS 13311-84-7) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 SANDOZ Flutamide (CAS 13311-84-7) Products Offered
12.8.5 SANDOZ Recent Development

13 Flutamide (CAS 13311-84-7) Manufacturing Cost Analysis
13.1 Flutamide (CAS 13311-84-7) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Flutamide (CAS 13311-84-7)
13.4 Flutamide (CAS 13311-84-7) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Flutamide (CAS 13311-84-7) Distributors List
14.3 Flutamide (CAS 13311-84-7) Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のフルタミド市場レポート2020年(Global Flutamide (CAS 13311-84-7) Sales Market Report 2020)]についてメールでお問い合わせはこちらでお願いします。